South Korea Next-Generation Sequencing Market

The South Korea next-generation sequencing market is projected to reach USD 386.3 million by 2031 from USD 201.0 million in 2026, at a CAGR of 14.0% during the forecast period. The next-generation sequencing market in South Korea is expanding rapidly due to declining sequencing costs, government-led genomic research initiatives, rising demand for precision medicine, and substantial investments in healthcare infrastructure and bioinformatics capabilities.

The next-generation sequencing market in South Korea is dominated by major players, including Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), QIAGEN (Netherlands), and PacBio (US), among others. Leading next-generation sequencing players stay competitive by expanding their product portfolios, forming strategic partnerships with government agencies and research institutions, advancing bioinformatics tools, enhancing sequencing platform capabilities, and delivering faster, cost-efficient, high-throughput sequencing solutions across diagnostics, drug discovery, and research applications.

To know about the assumptions considered for the study download the pdf brochure

Illumina, Inc. (US) is a leading provider of next-generation sequencing platforms and consumables serving the South Korean market through strategic collaborations with national genomic initiatives. The company has established partnerships with South Korean government agencies to support the development of a national genome library and advance precision medicine programs. Illumina delivers a comprehensive range of sequencing systems, reagents, and bioinformatics solutions designed for clinical diagnostics, cancer genomics, population health studies, and pharmaceutical research. With extensive experience in genomic analysis and a strong presence in the region, Illumina has positioned itself as a trusted partner for large-scale sequencing projects and institutional research programs across South Korea.

Thermo Fisher Scientific Inc. (US) is a technology-driven provider of next-generation sequencing instruments, consumables, and integrated workflows serving academic, clinical, and pharmaceutical customers in South Korea. The company offers end-to-end solutions that combine sequencing platforms, library preparation kits, data analysis software, and technical support into streamlined processes that reduce complexity and accelerate time to results. Their sequencing systems support applications ranging from targeted gene panels to whole genome sequencing, providing researchers and clinicians with flexible, scalable options for diverse genomic studies. Thermo Fisher's comprehensive product ecosystem and local technical support enable South Korean institutions to implement advanced sequencing capabilities with confidence in quality, reproducibility, and regulatory compliance.

MARKET RANKING

Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), QIAGEN (Netherlands), and PacBio (US) are the leading companies in the next-generation sequencing market in South Korea. Illumina is recognized for its comprehensive sequencing platforms and consumables portfolio, supported by strategic collaborations with South Korean government genomic initiatives and research institutions. Thermo Fisher Scientific specializes in integrated sequencing workflows, combining instruments, reagents, and bioinformatics tools to serve clinical diagnostics and pharmaceutical research applications. QIAGEN focuses on sample preparation technologies, library construction kits, and bioinformatics software that enable efficient NGS workflows across research and clinical laboratories.

Related Reports:

South Korea Next-Generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing (Consumables), Platforms, Bioinformatics), Application (Drug Discovery, Diagnostic, Agriculture) - Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com